- Home
- RENB vs CBUS Comparison
RENB vs CBUS Comparison
Compare RENB & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENB
- CBUS
- Stock Information
- Founded
- RENB 2011
- CBUS 2010
- Country
- RENB United States
- CBUS United States
- Employees
- RENB N/A
- CBUS N/A
- Industry
- RENB Biotechnology: Pharmaceutical Preparations
- CBUS Agricultural Chemicals
- Sector
- RENB Health Care
- CBUS Industrials
- Exchange
- RENB Nasdaq
- CBUS Nasdaq
- Market Cap
- RENB 121.3M
- CBUS 120.1M
- IPO Year
- RENB N/A
- CBUS 2017
- Fundamental
- Price
- RENB $0.82
- CBUS $2.08
- Analyst Decision
- RENB
- CBUS Strong Buy
- Analyst Count
- RENB 0
- CBUS 3
- Target Price
- RENB N/A
- CBUS $22.17
- AVG Volume (30 Days)
- RENB 543.5K
- CBUS 129.2K
- Earning Date
- RENB 02-19-2025
- CBUS 03-20-2025
- Dividend Yield
- RENB N/A
- CBUS N/A
- EPS Growth
- RENB N/A
- CBUS N/A
- EPS
- RENB N/A
- CBUS N/A
- Revenue
- RENB N/A
- CBUS $4,152,999.00
- Revenue This Year
- RENB N/A
- CBUS $132.42
- Revenue Next Year
- RENB N/A
- CBUS $97.96
- P/E Ratio
- RENB N/A
- CBUS N/A
- Revenue Growth
- RENB N/A
- CBUS 449.34
- 52 Week Low
- RENB $0.40
- CBUS $2.05
- 52 Week High
- RENB $3.38
- CBUS $23.18
- Technical
- Relative Strength Index (RSI)
- RENB 50.63
- CBUS 31.98
- Support Level
- RENB $0.69
- CBUS $2.39
- Resistance Level
- RENB $0.89
- CBUS $2.67
- Average True Range (ATR)
- RENB 0.07
- CBUS 0.19
- MACD
- RENB 0.02
- CBUS -0.01
- Stochastic Oscillator
- RENB 70.41
- CBUS 4.62
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.